STOCK TITAN

BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference

(Neutral)
(Neutral)
Tags

BioHarvest Sciences (NASDAQ: BHST) announced that CEO Zaki Rakib will present at the Canaccord Genuity 46th Annual Growth Conference, held August 11-13, 2026, in Boston, Massachusetts. The company presentation is scheduled for Wednesday, August 12, 2026, at 1:00 p.m. ET.

The in-person session will take place in Abigail Adams C at the InterContinental Hotel in Boston, with a publicly accessible live webcast available to online pre-registrants at the provided link. According to BioHarvest, investors can request one-on-one meetings with the company through their Canaccord Genuity representative. The conference connects global institutional investors with growth companies across Technology, Healthcare & Life Sciences, Sustainability, Industrials, and Consumer & Retail sectors.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 29, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its Chief Executive Officer, Zaki Rakib, will present at the upcoming Canaccord Genuity 46th Annual Growth Conference, to be held on August 11-13, 2026, in Boston, Massachusetts. In addition to presenting, Dr. Rakib will also be participating in one-on-one investor meetings from August 11-12.

Presentation Details:

The live online webcast is publicly accessible for all online pre-registrants, and registration is mandatory for in-person conference participation. Investors attending the conference may request a one-on-one meeting with BioHarvest Sciences through their Canaccord Genuity representative.

Canaccord Genuity's 46th Annual Growth Conference aims to bring together institutional investors from across the globe with some of the best and most promising growth companies in the Technology, Healthcare & Life Sciences, Sustainability, Industrials, and Consumer & Retail sectors. For more information, please visit the conference website.

About BioHarvest

BioHarvest (NASDAQ: BHST) (FSE: 8MV0) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based compounds, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking novel plant-based compounds, and as a creator of proprietary nutraceutical health and wellness products based on its botanical synthesis technology. To learn more, please visit www.bioharvest.com.

Forward-Looking Statements

This news release may contain forward-looking statements within the meaning of applicable securities laws. These statements are based on management's current expectations, beliefs, and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Readers are cautioned not to place undue reliance on forward-looking statements. The Company does not undertake any obligation to update forward-looking statements except as required by applicable law. Additional information is contained in the Company's SEC filings, available at http://www.sec.gov.

BioHarvest Company Contact
Dave Ryan, VP Investor Relations
(604) 622-1186 | info@bioharvest.com

Investor Relations Contact:
Chuck Padala, Managing Director
LifeSci Advisors
chuck@lifesciadvisors.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/307087

FAQ

When will BioHarvest Sciences (NASDAQ: BHST) present at the Canaccord Genuity 46th Annual Growth Conference in 2026?

BioHarvest Sciences will present on Wednesday, August 12, 2026, at 1:00 p.m. ET. According to BioHarvest, the presentation is part of the Canaccord Genuity 46th Annual Growth Conference held August 11-13, 2026, in Boston, Massachusetts.

Who is presenting for BioHarvest Sciences (BHST) at the Canaccord Genuity 2026 Growth Conference?

BioHarvest Sciences will be represented by its Chief Executive Officer, Zaki Rakib. According to BioHarvest, Dr. Rakib will deliver the company presentation and also participate in one-on-one investor meetings on August 11-12, 2026, during the conference.

How can investors access the BioHarvest Sciences (BHST) presentation webcast on August 12, 2026?

Investors can access the BioHarvest Sciences webcast via a public online link, subject to pre-registration. According to BioHarvest, the live webcast is available to all online pre-registrants at the specified Summitcast URL provided in the conference details.

Can investors schedule one-on-one meetings with BioHarvest Sciences (BHST) at the Canaccord Genuity 46th Annual Growth Conference?

Yes, investors can request one-on-one meetings with BioHarvest Sciences during the conference. According to BioHarvest, such meetings should be arranged through each investor’s Canaccord Genuity representative for August 11-12, 2026, in Boston.

Where is the in-person BioHarvest Sciences (BHST) session being held during the Canaccord Genuity 2026 conference?

The in-person BioHarvest Sciences presentation will be held in Abigail Adams C at the InterContinental Hotel, Boston, MA. According to BioHarvest, this session is part of the broader three-day Canaccord Genuity 46th Annual Growth Conference.

What sectors does the Canaccord Genuity 46th Annual Growth Conference, featuring BioHarvest Sciences (BHST), focus on?

The conference focuses on growth companies in Technology, Healthcare & Life Sciences, Sustainability, Industrials, and Consumer & Retail. According to BioHarvest, the event brings together global institutional investors with promising companies across these sectors, including BioHarvest.